The DOI matches its Crossref record; 254 of the 254 references it cites were found in a registry or an index.
Tumor-associated neutrophils and neutrophil-targeted cancer therapies
Open accessAbstract
Neutrophils are the frontline cells in response to microbial infections and are involved in a range of inflammatory disorders in the body. In recent years, neutrophils have gained considerable attention in their involvement of complex roles in tumor development and progression. Tumor-associated neutrophils (TANs) that accumulate in local region could be triggered by external stimuli from tumor microenvironment (TME) and switch between anti- and pro-tumor phenotypes. The anti-tumor neutrophils kill tumor cells through direct cytotoxic effects as well as indirect effects by activating adaptive immune responses. In contrast, the pro-tumor phenotype of neutrophils might be associated with cell proliferation, angiogenesis, and immunosuppression in TME. More recently, neutrophils have been proposed as a potential target in cancer therapy for their ability to diminish the pro-tumor pathways, such as by immune checkpoint blockade. This review discusses the complex roles of neutrophils in TME and highlights the strategies in neutrophil targeting in cancer treatment with a particular focus on the progresses of ongoing clinical trials involving neutrophil-targeted therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–254 of 254
Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis
Sun, R., Xiong, Y.-Y., Liu, H., Gao, C., Su, L., Weng, J., Yuan, X., Zhang, D., & Feng, J. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100825 · Cited by 119
Recent discoveries concerning the tumor - mesenchymal stem cell interactions
Lazennec, G., & Lam, P. Y. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.10.004 · Cited by 117
A Method for Identification and Analysis of Non-Overlapping Myeloid Immunophenotypes in Humans
Gustafson, M. P., Lin, Y., Maas, M. L., Keulen, V. P. V., Johnston, P. B., Peikert, T., Gastineau, D. A., & Dietz, A. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121546 · Cited by 114
Morris, K. T., Khan, H. Z., Ahmad, A., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.822 · Cited by 111
Inoue, M., Nakashima, R., Enomoto, M., Koike, Y., Zhao, X. L., Yip, K. W., Huang, S. H., Waldron, J. N., Ikura, M., Liu, F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07550-x · Cited by 108
Li, W., Zhang, X., Chen, Y., Xie, Y., Liu, J., Feng, Q., Wang, Y., Yuan, W., & Ma, J. (2016) · Protein & Cell · doi:10.1007/s13238-015-0237-2 · Cited by 104
Gomes, T., Várady, C. B. S., Lourenço, A. L., Mizurini, D. M., Rondon, A. M. R., Leal, A. C., Gonçalves, B. S., Bou‐Habib, D. C., Medei, E. H., & Monteiro, R. Q. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02088 · Cited by 104
Kiss, M., Walle, L. V., Saavedra, P. H. V., Lebegge, E., Damme, H. V., Murgaski, A., Qian, J., Ehling, M., Pretto, S., Bolli, E., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0431 · Cited by 102
Itatani, Y., Yamamoto, T. S., Zhong, C., Molinolo, A., Ruppel, J., Hegde, P. S., Taketo, M. M., & Ferrara, N. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008112117 · Cited by 99
Human polymorphonuclear neutrophils specifically recognize and kill cancerous cells
Yan, J., Kloecker, G. H., Fleming, C., Bousamra, M., Hansen, R., Hu, X., Ding, C., Cai, Y., Xiang, D., Donninger, H., et al. (2014) · OncoImmunology · doi:10.4161/15384101.2014.950163 · Cited by 98
Neutrophils, Nitric Oxide Synthase, and Mutations in the Mutatect Murine Tumor Model
Sandhu, J. K., Privora, H., Wenckebach, G. F. C., & Birnboim, H. C. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64755-4 · Cited by 97
Effector Mechanisms of Recombinant IgA Antibodies against Epidermal Growth Factor Receptor
Dechant, M., Beyer, T. D., Schneider‐Merck, T., Weisner, W., Peipp, M., van de Winkel, J. G. J., & Valerius, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2936 · Cited by 96
Zhang, X., Wang, Y., Fan, J., Chen, W., Luan, J., Mei, X., Wang, S., Li, Y., Ye, L., Li, S., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0812-9 · Cited by 96
Stockmeyer, B., Valerius, T., Repp, R., Heijnen, I., Bühring, H. ‐., Deo, Y. M., Kalden, J. R., Gramatzki, M., & van de Winkel, J. G. J. (1997) · PubMed · Cited by 94
NETosis in Cancer – Platelet–Neutrophil Crosstalk Promotes Tumor-Associated Pathology
Olsson, A., & Cedervall, J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00373 · Cited by 91
Chen, C.-L., Wang, Y., Huang, C.-Y., Zhou, Z.-Q., Zhao, J.-J., Zhang, X.-F., Pan, Q., Wu, J.-X., Weng, D., Tang, Y., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1373234 · Cited by 90
Normalization of Tumor Vasculature by Oxygen Microbubbles with Ultrasound
Ho, Y.-J., Chu, S.-W., Liao, E., Fan, C., Chan, H., Wei, K., & Yeh, C. (2019) · Theranostics · doi:10.7150/thno.37750 · Cited by 89
Immunoglobulin A: FcαRI Interactions Induce Neutrophil Migration Through Release of Leukotriene B4
van der Steen, L. P. E., Tuk, C. W., Bakema, J. E., Kooij, G., Reijerkerk, A., Vidarsson, G., Bouma, G., Kraal, G., de Vries, H. E., Beelen, R. H. J., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.047 · Cited by 88
Haqqani, A. S., Sandhu, J. K., & Birnboim, H. C. (2000) · Neoplasia · doi:10.1038/sj.neo.7900110 · Cited by 88
Zhou, G., Peng, K., Song, Y., Yang, W., Shu, W., Yu, T., Lin, Y., Lin, M., Wei, Q., Chen, C., et al. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx142 · Cited by 86
Gaida, M. M., Steffen, T., Günther, F. A., Tschaharganeh, D. F., Felix, K., Bergmann, F., Schirmacher, P., & Hänsch, G. M. (2012) · European Journal of Immunology · doi:10.1002/eji.201242628 · Cited by 83
IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis
Gross, A. C., Cam, H., Phelps, D. A., Saraf, A. J., Bid, H. K., Cam, M., London, C. A., Winget, S. A., Arnold, M. A., Brandolini, L., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99791 · Cited by 82
Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer
Emmons, T. R., Giridharan, T., Singel, K. L., Khan, A. N. H., Ricciuti, J., Howard, K., Toro, S. L. S.-D., Debreceni, I. L., Aarts, C. E. M., Brouwer, M. C., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0922 · Cited by 80
Vagulienė, N., Žemaitis, M., Lavinskienė, S., Miliauskas, S., & Sakalauskas, R. (2013) · BMC Immunology · doi:10.1186/1471-2172-14-36 · Cited by 77
Tulotta, C., Stefanescu, C., Chen, Q., Torraca, V., Meijer, A. H., & Snaar-Jagalska, E. B. (2019) · Scientific Reports · doi:10.1038/s41598-019-38643-2 · Cited by 77
Regulation of Constitutive TCR Internalization by the ζ-Chain
D’Oro, U., Munitić, I., Chacko, G. W., Karpova, T., McNally, J. G., & Ashwell, J. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6269 · Cited by 75
Hattar, K., Franz, K., Ludwig, M., Sibelius, U., Wilhelm, J., Lohmeyer, J., Savai, R., Subtil, F. S. B., Dahlem, G., Eul, B. G., et al. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1606-z · Cited by 75
Garley, M., Jabłońska, E., & Dabrowska, D. M. (2016) · Tumor Biology · doi:10.1007/s13277-016-5328-z · Cited by 73
Sun, B., Qin, W., Song, M., Liu, L., Yao, Y., Qi, X., & Sun, H. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.29297 · Cited by 73
Eruslanov, E. B. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-1976-0 · Cited by 72
Riise, R. E., Bernson, E., Aurelius, J., Martner, A., Pesce, S., Chiesa, M. D., Marcenaro, E., Bylund, J., Hellstrand, K., Moretta, L., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500709 · Cited by 69
Polymorphonuclear Granulocytes Induce Antibody-Dependent Apoptosis in Human Breast Cancer Cells
Stockmeyer, B., Beyer, T. D., Neuhuber, W., Repp, R., Kalden, J. R., Valerius, T., & i, M. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5124 · Cited by 69
NK Cells Control Tumor-Promoting Function of Neutrophils in Mice
Ogura, K., Sato‐Matsushita, M., Yamamoto, S., Hori, T., Sasahara, M., Iwakura, Y., Saiki, I., Tahara, H., & Hayakawa, Y. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0204 · Cited by 65
Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas
Savarese, T. M., Mitchell, K., McQuain, C., Campbell, C. L., Guardiani, R., Wuu, J., Ollari, C., Reale, F. R., Nelson, B. E., Chen, A., et al. (2001) · Cancer Letters · doi:10.1016/s0304-3835(00)00623-6 · Cited by 60
The pro-tumor effect and the anti-tumor effect of neutrophils extracellular traps
Liu, Y., & Liu, L. (2019) · BioScience Trends · doi:10.5582/bst.2019.01326 · Cited by 58
Sun, R., Luo, J., Li, D., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2181 · Cited by 56
TREM-1 promotes intestinal tumorigenesis
Saurer, L., Zysset, D., Rihs, S., Mager, L. F., Gusberti, M., Simillion, C., Lugli, A., Zlobec, I., Krebs, P., & Mueller, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-14516-4 · Cited by 53
Emodin regulates neutrophil phenotypes to prevent hypercoagulation and lung carcinogenesis
Li, Z., Lin, Y., Zhang, S., Zhou, L., Yan, G., Wang, Y., Zhang, M., Wang, M., Lin, H., Tong, Q., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1838-y · Cited by 52
Khou, S., Popa, A., Luci, C., Bihl, F., Meghraoui, A., Bourdely, P., Salavagione, E., Cosson, E., Rubod, A., Cazareth, J., et al. (2020) · Cancers · doi:10.3390/cancers12071860 · Cited by 51
Jiang, J., Zhang, Y., Peng, K., Wang, Q., Hong, X., Li, H., Fan, G., Zhang, Z., Gong, T., & Sun, X. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.05.009 · Cited by 46
Current advances of targeting HGF/c-Met pathway in gastric cancer
Anestis, A., Zoi, I., & Karamouzis, M. V. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.42 · Cited by 44
Pivotal Role for Cxcr2 in Regulating Tumor-Associated Neutrophil in Breast Cancer
Timaxian, C., Vogel, C. F. A., Orcel, C., Vetter, D., Durochat, C., Chinal, C., NGuyen, P., Aknin, M.-L. R., Mercier‐Nomé, F., Davy, M., et al. (2021) · Cancers · doi:10.3390/cancers13112584 · Cited by 44
Liu, Y., O’Leary, C. E., Wang, L. S., Bhatti, T. R., Dai, N., Kapoor, V., Liu, P., Mei, J., Guo, L., Oliver, P. M., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1061175 · Cited by 43
Chu, T., Huang, S., Yang, S., Li, C., Lin, H.-W., Weng, B., Yang, S., Huang, S., Wu, J., Chang, Y., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0886-3 · Cited by 43
Boissière‐Michot, F., Jacot, W., Massol, O., Mollévi, C., & Lazennec, G. (2021) · Cancers · doi:10.3390/cancers13102328 · Cited by 42
Neutrophils Deficient in Innate Suppressor IRAK-M Enhances Anti-tumor Immune Responses
Zhang, Y., Diao, N., Lee, C. K., Chu, H. W., Bai, L., & Li, L. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.09.019 · Cited by 41
Lin, Q., Fang, X., Liang, G., Luo, Q., Cen, Y., Shi, Y., Jia, S., Li, J., Yang, W., Sanders, A. J., et al. (2021) · Cancers · doi:10.3390/cancers13225703 · Cited by 41
Actin Polymerization Induces Shedding of FcγRIIIb (CD16) from Human Neutrophils
Middelhoven, P. J., van Buul, J. D., Kleijer, M., Roos, D., & Hordijk, P. L. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0244 · Cited by 38
Tumor Angiogenesis Mediated by Myeloid Cells Is Negatively Regulated by CEACAM1
Lu, R. O., Kujawski, M., Pan, H., & Shively, J. E. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3016 · Cited by 36
Yui, S., Tomita, K., Kudo, T., Ando, S., & Yamazaki, M. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00097.x · Cited by 34
Emerging Role of Neutrophils in the Thrombosis of Chronic Myeloproliferative Neoplasms
Ferrer‐Marín, F., Cuenca‐Zamora, E. J., Guijarro-Carrillo, P. J., & Teruel‐Montoya, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031143 · Cited by 33
Boivin, G., Ancey, P., de Silly, R. V., Kalambaden, P., Contat, C., Petit, B., Ollivier, J., Bourhis, J., Meylan, E., & Vozenin, M. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1876597 · Cited by 29
Yoshida, M., Taguchi, A., Kawana, K., Ogishima, J., Adachi, K., Kawata, A., Nakamura, H., Sato, M., Fujimoto, A., Inoue, T., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4504 · Cited by 20
Nakagawa, T., Natsume, A., Satoh, M., & Niwa, R. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.10.029 · Cited by 17
Cited by
Neutrophils and Neutrophil-Based Drug Delivery Systems in Anti-Cancer Therapy
Wahnou, H., El Kebbaj, R., Hba, S., Ouadghiri, Z., El Faqer, O., Pinon, A., Liagre, B., Limami, Y., & Duval, R. E. (2025) · Cancers · doi:10.3390/cancers17071232 · Cited by 35
Chen, L., Huang, Y., Zhang, N., Qu, J., Fang, Y., Fu, J., Yuan, Y., Zhang, Q., Li, H., Wen, Z., et al. (2024) · MedComm · doi:10.1002/mco2.654 · Cited by 15
Metadata
- Authors
- Que, H., Fu, Q., Lan, T., Tian, X., & Wei, X.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 1877
- Issue
- 5
- Pages
- 188762
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W4285600182
- Cited by
- 312
- References
- 254
- FWCI
- 19.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.